Market revenue in 2023 | USD 23.5 million |
Market revenue in 2030 | USD 43.3 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Medical devices |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drugs, Biologics, Medical Devices |
Key market players worldwide | PAREXEL, Icon PLC, IQVIA Holdings Inc, Syneos Health, Premier Cryogenics, ProPharma Group, PharmaLex, Labcorp Holdings Inc, Perella Weinberg Partners Ordinary Shares - Class A, Navigant Consulting Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory consulting outsourcing services market will help companies and investors design strategic landscapes.
Medical devices was the largest segment with a revenue share of 40% in 2023. Horizon Databook has segmented the South Korea regulatory consulting outsourcing services market based on drugs, biologics, medical devices covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea regulatory consulting outsourcing services market , including forecasts for subscribers. This country databook contains high-level insights into South Korea regulatory consulting outsourcing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account